G
Live / Applied — Second extension granted (statement of use) (as of 19 Feb 2026)
What this means for you
Not registered yet, but its 26 Oct 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98241703
- Mark type
- Word mark
- Filed
- 26 Oct 2023
- Published for opposition
- 31 Dec 2024
- Attorney of record
- Rachelle A. Dubow, Esq.
Goods and services
- Class 001 — Chemicals: Chemical reagents and RNA sequences being chemical reagents for agricultural purposes, and not medical or veterinary purposes, namely, for crop protection and to improve plant health and plant yield; chemical preparations for the treatment of seeds, plants and crops to improve plant health and yield
- Class 005 — Pharmaceuticals: Chemical reagents and RNA sequences, namely, insecticides, pesticides, and fungicides, used to repel or destroy insects, pests, parasites, and vermin; Agricultural products, namely, insecticides, herbicides, pesticides, fungicides; preparations for destroying vermin; Chemical reagents and RNA sequences for improving bee health; Pharmaceutical products and veterinary products for human and animal health in the nature of vaccines and RNA therapeutic pharmaceuticals for the treatment of parasitic infection or infestations, infectious diseases, neurological diseases, metabolic diseases, cardiovascular diseases, respiratory diseases, immune system diseases, and cancer; Antibiotics; Vaccines; Gene therapy products, namely, mRNA therapeutic nucleic acids and siRNA therapeutic nucleic acids for medical or clinical use for the treatment of infectious diseases, respiratory diseases, immune system diseases, cardiovascular diseases, and cancer; RNA in the nature of vaccines and therapeutics for scientific, research, medical, pharmaceutical, veterinary, agricultural, industrial and manufacturing use for the treatment of infectious diseases, neurological diseases, metabolic diseases, cardiovascular diseases, respiratory diseases, immune system diseases, parasitic infection or infestation, and cancer
- Class 040 — Treatment of materials: Cell-Free processing and manufacturing of RNA for others; biological manufacturing and cell-free processing of RNA for others
- Class 042 — Scientific and technological services: Research and development services in the field of RNA for scientific, engineering, research, medical, pharmaceutical, veterinary, agricultural, chemical and energy production, industrial and manufacturing use; research and development services in the field of synthetic and recombinant biology and formulations; custom design of pesticides, insecticides, and fungicides, computer-aided design services and engineering in the field of producing RNA and cell-free processing; research and development services in the field of producing, manufacturing, and processing of RNA and RNA formulations for scientific, research, medical, pharmaceutical, veterinary, agricultural food, chemical and energy production, industrial and manufacturing use; research and development services in the field of formulations for the delivery of RNA for scientific, research, medical, pharmaceutical, veterinary, agricultural, chemical and energy production, industrial and manufacturing use
Owner
- GreenLight Biosciences, Inc., Durham, NC, US
- GreenLight Biosciences, Inc., Durham, NC, US
Prosecution history
- 20 Feb 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 19 Feb 2026 — SOU EXTENSION 2 GRANTED
- 19 Feb 2026 — SOU EXTENSION 2 FILED
- 19 Feb 2026 — SOU TEAS EXTENSION RECEIVED
- 19 Aug 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Aug 2025 — SOU EXTENSION 1 GRANTED
- 18 Aug 2025 — SOU EXTENSION 1 FILED
- 18 Aug 2025 — SOU TEAS EXTENSION RECEIVED
- 25 Feb 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 31 Dec 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 31 Dec 2024 — PUBLISHED FOR OPPOSITION
- 25 Dec 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 06 Dec 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 06 Dec 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 06 Dec 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE